HOME > BUSINESS > Government launches mobile app to show drug prices

Government launches mobile app to show drug prices

hanumThe Union Minister of Chemicals & Fertilizers Ananth Kumar launched a mobile app to help buyers find the correct price of medicines.

Called ‘Pharma Sahi Daam’- the app shows the maximum retail price fixed by National Pharmaceutical Pricing Authority (NPPA) for various scheduled drugs on real time basis.

On the occassion of NPPA Foundation Day, the Minister appealed to the industry leaders, state governments and other departments in pooling efforts to make available medicines at affordable prices to the common man.

¨In the last two and a half years, almost 900 formulations have been brought under the price control, providing a saving of about 5000 crores to the consumers. National Pharmaceutical Pricing Authority (NPPA) has already come out with ceiling price of 368 new drugs within 6 months of the issue of New National List of Essential Medicines-2015¨ he further added.

The Minister said that he is pursuing the case for making an independent Ministry for Pharmaceuticals so that all decisions regarding the industry could be taken under a single roof.

The pharmaceutical industry has risen to almost $37 billion and Indian medicines are being exported to over 200 countries. Pharmaceuticals is a sunrise industry and the Government is keen to provide support to it through various means like pharmaceutical parks, medical devices parks, pharmaceutical clusters and promotion of innovation through Atal Innovation Scheme, he added.

A strategy is being adopted to provide cheap medicines to the common man- one is through regulating the prices by NPPA and another is opening of PM Jan Aushadhi Stores. He said that within one year, 3000 PM Jan Aushadhi Stores will be opened in the country covering all districts and administrative divisions.

The Minister further said that most of the medicines in Jan Aushadhi stores cost 30 to 40 per cent as compared to the market cost and no medicine in Jan Aushadhi Store is more than 50 per cent of the market cost.

Follow ULTRA.news
Supreme Court dismisses Center’s reasons for not appointing Lokpal The Supreme Court has dismissed the government of India's stand that it cannot appoint the Lokpal as there was no leader of the opposition.The court's decision came on a bunch of petitions seeking the appointment of a Lokpal is likely to lead to the first ever appointment...
Govt likely to intensify efforts to create All India Judicial Service High Court of Karnataka, DharwadDespite setbacks and opposition from both state governments and the judiciary, the central government is not ready to give up the proposal to set up an all India service for recruitment of judges modeled on the Indian Administrative Service an...
Air India lifts ban on Shiva Sena MP Ravindra Gaikwad Air India has been told to remove Shiva Sena MP Ravindra Gaikwad from its 'no fly list' after pressure from Gaikwad's party on the central government.According to reports, the MP had tried to book flight tickets again today morning, but could not.However, Air India ha...
Govt to strengthen official email service to lure employees from pvt providers Government of India is overhauling its email system in an effort to encourage government officials to use only their official email accounts for official purposes, the IT department said.At present, many government officials use private email services such as Gmail and Yahoo ...
Trademark registration up three fold in India National Institute of Intellectual Property Mgmt, DelhiThe number of trademarks awarded by the India's Controller General of Patents, Designs & Trade Marks has jumped threefold this financial year, according to data obtained from the Patent Office.A total of 2.11 lak...
Govt to bring 532 welfare schemes under Aadhaar-based direct benefit transfer Logo for LPG DBT schemeThe finance ministry has conducted an examination of the existing welfare and subsidy schemes of the central governments and identified 532 of them as being suitable to be migrated to the 'direct benefit transfer' or DBT model of disbursing of funds. ...
39 government websites hacked in India in 2 months An increasing number of government department websites get hacked every year, according to data obtained from the Department of Information Technology.A total of 39 websites belonging to central government ministries and state governments were hacked in the first two months o...
Only 50% have responded to Operation Clean Money queries A flyer for Operation Clean MoneyThe number of people who have given their responses under the government's 'Operation Clean Money' has reached 8.38 lakh as of Mar 9, slightly less than half the 17.92 lakh people to whom questions have been sent.The questions were sent i...
Govt of India starts crack down on low-quality medicine makers The government of India has started conducting inspections at drug manufacturing units across the country to prevent the production of low-quality drugs and medicines in India.Typically, inspections are conducted by state authorities, while central agencies largely confin...
Cipla redraws Iran plans with new agreement, to invest Rs 121 cr Cipla said its wholly owned subsidiary of the Company in Netherlands will set up a 75% joint venture with Ahran Tejarat Company for manufacturing and marketing of pharmaceutical products in Iran.An earlier agreement executed by the Company with the Iranian firm has been termi...
Bliss GVS Healthcare wins three-year contract worth Rs 760 cr from Kenya Bliss GVS Healthcare Ltd said it won a three year contract worth $111.40 mln (Rs 760 cr) from Aon Kenya Insurance Brokers Ltd for provision of medical health care services in Kenya. Bliss GVS Pharma Ltd is a pharmaceutical company based in Mumbai, India.Bliss GVS...
Alembic Pharmaceuticals receives FDA approval for hypertension tablets Alembic Pharmaceuticals Ltd said it received approval from the United States Food & Drug Administration for its abbreviated new drug application for Telmisartan and Amlodipine tablets for hypertension.The Telmisartan and Amlodipine Tablets are equivalent to the Twynsta ta...
Minister refuses to answer Parliament on amendment to anti-corruption bill The ministry of personnel, public grievances and pensions has refused to provide an answer to the Parliament on whether the proposed amendment to the Prevention of Corruption Act will make investigation of corruption charges against officials difficult.The ministry -- whi...
40% of High Court judge positions are vacant, 30% in trial courts A large proportion of the posts for judges in the various High Courts in India are lying vacant, resulting in painfully slow dispensation of justice, according to law ministry numbers.Out of a total of 1079 posts of judges in all the High Courts in India, a whopping 442 are l...
Lupin launches injectable iron formulations in India Pharma major Lupin Limited said it launched Iron Isomaltoside injectable iron formulation under two brand names “Isofer” and “Jilazo” in India.Lupin acquired the exclusive rights to market, distribute and sell the injectable formulation from Denmark based Pharmacosmos A/S.The...
Dr Reddy’s Labs launches osteoporosis drug in the US Dr Reddy's Laboratories Ltd said it launched raloxifene hydrochloride tablets --used to treat osteoporosis -- in the US market.Raloxifene hydrochloride tablets are a therapeutic equivalent generic version of Evista (raloxifene hydrochloride) tablets. A generic drug is a pharm...
RPP Infra Projects wins Rs 254 mln contract from TN Civil Supplies RPP Infra projects Ltd said it received a contract worth Rs 254 mln from Tamil Nadu Civil Supplies Corporation to construct scientific storage godown at Kodavasal village & taluk in Thiruvarur district.The godown is of 2500 MT and is to be completed within 24 months.R...
Sun Pharma to get dengue vaccine technology from ICGEB Pharma major Sun Pharma said it tied up with research organization International Centre for Genetic Engineering and Biotechnology to develop vaccines for dengue.The vaccine is targeted against all the four serotypes of Dengue virus that cause disease in humans and is being de...
Aarti Industries to return Rs 96 cr to shareholders via buyback Speciality Chemicals company Aarti Industries Ltd said it will buy back12 lakh equity shares at Rs 800 each, aggregating to Rs 96 cr.The company´s Board of Directors approved the equity shares -- representing up to 1.44% of the company's base."The public announcement sett...
Marksans Pharma gets USFDA approval for synthetic Vitamin D tablets Marksans Pharma Ltd said the United States Food & Drug Administration has given its approval for its paricalcitol capsules -- a synthetic equivalent of Vitamin D.Vitamin D is important for the absorption of Calcium from the stomach and for the functioning of Calcium in t...
India overdependent on China for medicines – study India may have emerged as a key supplier of generic and affordable medicine for the world market, but it has an "overwhelming dependence" on China for the raw material required to produce these drugs, industry association Assocham said.Indian companies depend on China to supp...
J&K to get new IIM campus with Rs 62 crore investment The Government has approved the establishment of Indian Institute of Management at Jammu in a temporary campus at Old Government College of Engineering & Technology from the Academic Year 2016-17.The project will involve a cost of Rs 62 crore in temporary campus for the i...
Lupin licenses taste-masking technology from Monosol for paediatric tablets Pharma Major Lupin Ltd. said its US subsidiary, Lupin Pharmaceutical Inc., has agreed to license technology from Monosol Rx to develop multiple paediatric-focused products.Lupin would develop the pediatric products utilizing MonoSol Rx’s proprietary PharmFilm drug delivery ...
Cadila to launch immunosuppressant drug in India Cadila Healthcare, a Ahmedabad headquartered pharmaceutical company owned by Zydus Group, said it has partnered with Switzerland-based global biopharmaceutical company Neovii to launch an drug to reduce the strength of the body's immune system in India.The drug named Grafalon...
Cauvery Dispute: Centre constitutes high level technical team Govt of India has constituted a high level technical team to visit the Cauvery basin area on the 7th of this month to assess the ground realities in the basin.The team will meet at Bengaluru for a preparatory meeting and subsequent visit to the Cauvery basin area for assessin...